Education
About Us
Working with TipRanks
Follow Us
Artivion (AORT)
NYSE:AORT
AORT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$19.36 - $32.33
Previous CloseN/A
Volume97.41K
Average Volume (3M)522.77K
Market Cap
$1.03B
Enterprise Value$1.51B
Total Cash (Recent Filing)$32.40M
Total Debt (Recent Filing)$1.80M
Price to Earnings (P/E)―
Beta1.49
Next Earnings
May 01, 2025EPS Estimate
-0.12Last Dividend Ex-Date
Dec 09, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-0.32
Shares Outstanding42,047,890
10 Day Avg. Volume418,342
30 Day Avg. Volume522,772
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.64
Price to Cash Flow (P/CF)25.30
P/FCF Ratio7.80
Enterprise Value/Market Cap1.46
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.05
Enterprise Value/Ebitda37.05
Forecast
1Y Price Target
$32.40Price Target Upside31.81% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
---
Artivion News
PremiumCompany Announcements
Artivion Inc. Reports Strong 2024 Earnings Amid Challenges
PremiumCompany Announcements
Artivion Inc. Reports Strong 2024 Financial Results
---
Bulls Say, Bears Say
Bulls Say
Market OpportunityExpectations for AORT to receive a premarket approval could expand its market coverage, representing a significant annual US market opportunity.
Operational RecoveryDespite the cybersecurity attack, Artivion is now operating near full capacity and expects significant revenue growth in the year.
Product Approval And GrowthThe earlier-than-expected approval of the AMDS humanitarian-device-exemption is anticipated to positively contribute to 2025 top-line growth.
Bears Say
Cybersecurity ImpactThe cyber incident is expected to continue affecting the company's performance in the immediate future, with management projecting lower 1Q25 revenues compared to previous estimates.
Financial PerformanceThe December cybersecurity breach led to lower-than-expected 4Q24 sales, impacting the company's financial performance.
Stock ValuationThe price target was lowered to $32 from $34, given the cybersecurity issue.
---
Ownership Overview
5.66% Insiders
26.29% Mutual Funds
26.32% Other Institutional Investors
19.82% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AORT FAQ
What was Artivion’s price range in the past 12 months?
Artivion lowest stock price was $19.36 and its highest was $32.33 in the past 12 months.
What is Artivion’s market cap?
Artivion’s market cap is $1.03B.
When is Artivion’s upcoming earnings report date?
Artivion’s upcoming earnings report date is May 01, 2025 which is in 29 days.
How were Artivion’s earnings last quarter?
Artivion released its earnings results on Feb 24, 2025. The company reported -$0.39 earnings per share for the quarter, missing the consensus estimate of -$0.065 by -$0.325.
Is Artivion overvalued?
According to Wall Street analysts Artivion’s price is currently Undervalued.
Does Artivion pay dividends?
Artivion pays a Quarterly dividend of $0.029 which represents an annual dividend yield of N/A. See more information on Artivion dividends here
What is Artivion’s EPS estimate?
Artivion’s EPS estimate is -0.12.
How many shares outstanding does Artivion have?
Artivion has 42,047,890 shares outstanding.
What happened to Artivion’s price movement after its last earnings report?
Artivion reported an EPS of -$0.39 in its last earnings report, missing expectations of -$0.065. Following the earnings report the stock price went down -8.223%.
Which hedge fund is a major shareholder of Artivion?
Currently, no hedge funds are holding shares in AORT
---
Artivion Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$32.40 (31.81% Upside)
$32.40 (31.81% Upside)
Blogger Sentiment
Bullish
AORT Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 70.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.5%
Last 30 Days ▼ 6.6%
Last 30 Days ▼ 6.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.16%
12-Months-Change
Fundamentals
Return on Equity
-4.78%
Trailing 12-Months
Asset Growth
-0.42%
Trailing 12-Months
Company Description
Artivion
Artivion, Inc. (AORT) is a medical device company that focuses on developing, manufacturing, and commercializing innovative technologies and solutions for treating aortic diseases. The company's product portfolio includes heart valves, surgical grafts, and other cardiovascular devices designed to address complex cardiac conditions. Artivion operates in the healthcare sector, specifically within the cardiovascular device industry, aiming to improve patient outcomes through its advanced medical products.
---
AORT Company Deck
---
AORT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a strong financial performance for 2024, with impressive revenue and EBITDA growth and successful product approvals. However, the company faced challenges due to a cybersecurity incident that impacted Q4 results and led to delays in product processing and PMA approval for AMDS. Despite these setbacks, the positive developments in product approvals and international growth suggest optimism for 2025.Read More>---
AORT Stock 12 Month Forecast
Average Price Target
$32.40
▲(31.81% Upside)
Technical Analysis
Best Analysts Covering AORT
1 Year
1 Year Success Rate
20/35 ratings generated profit
1 Year Average Return
+10.95%
reiterated a buy rating 2 months ago
Copying Suraj Kalia's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +10.95% per trade.
---